Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-06

Clinical Trial Update: Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

View source ↗

Summary

A clinical trial update studying how hypoxia-related factors affect patients with hereditary hemorrhagic telangiectasia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Essen | Conditions: Hereditary Hemorrhagic Telangiectasia | Status: RECRUITING